A 4015 New Jersey General Assembly · 2024-2025 Regular Session

Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

This bill requires New Jersey pharmacies to display a notice and provide a pamphlet about insulin manufacturer assistance programs at checkout. Pharmacies must give these materials to anyone purchasing insulin or requesting them, with the Department of Banking and Insurance creating the content. The information helps insulin users access manufacturer programs that may reduce their out-of-pocket costs. It directly affects pharmacies (by requiring new disclosures) and insulin patients (by improving access to cost-saving resources).
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2024
Committee Review
Floor Vote
Governor
Introduced Mar 7, 2024 Last action May 22, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
1
Committee
1
May 15, 2025
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Mar 7, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 4 co-sponsors

Sponsors